APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lurasidone Hydrochloride Generics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lurasidone Hydrochloride Generics Market Outlook and Growth Opportunities 2026

Report ID 174009460427 December 2025202 pages

Choose your research edition.

Industry ResearchLurasidone Hydrochloride Generics Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Lurasidone Hydrochloride Generics Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Lurasidone Hydrochloride Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lurasidone Hydrochloride Generics Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Lurasidone Hydrochloride Generics Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Lurasidone Hydrochloride Generics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lurasidone Hydrochloride Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lurasidone Hydrochloride Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lurasidone Hydrochloride Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lurasidone Hydrochloride Generics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lurasidone Hydrochloride Generics market include Chia Tai Tianqing Pharmaceutical, Zhejiang Huahai Pharmaceutical, YaoPharma, Yangtze River Pharmaceutical, SJZ No.4 Pharmaceutical, Shandong Jewim Pharmaceutical, Qilu Pharmaceutical, Hansoh Pharma and Hisun Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lurasidone Hydrochloride Generics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lurasidone Hydrochloride Generics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lurasidone Hydrochloride Generics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lurasidone Hydrochloride Generics market size, projected growth trends, production technologies, key applications, and end-use industries.

Lurasidone Hydrochloride Generics Segment by Company

Chia Tai Tianqing Pharmaceutical

Zhejiang Huahai Pharmaceutical

YaoPharma

Yangtze River Pharmaceutical

SJZ No.4 Pharmaceutical

Shandong Jewim Pharmaceutical

Qilu Pharmaceutical

Hansoh Pharma

Hisun Pharmaceuticals

Cisen Pharmaceutical

Changzhou Pharmaceutical Factory

Zydus

Sun Pharmaceuticals

MSN

Lupin

Dr. Reddy's Laboratories

Amneal

Alkem

Alembic pharmaceuticals

Accord Healthcare

Lurasidone Hydrochloride Generics Segment by Type

20mg per Tablet

40mg per Tablet

60mg per Tablet

80mg per Tablet

120mg per Tablet

Lurasidone Hydrochloride Generics Segment by Application

Schizophrenia

Bipolar Depression

Lurasidone Hydrochloride Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lurasidone Hydrochloride Generics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lurasidone Hydrochloride Generics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lurasidone Hydrochloride Generics significant trends, drivers, influence factors in global and regions.

6. To analyze Lurasidone Hydrochloride Generics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone Hydrochloride Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lurasidone Hydrochloride Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone Hydrochloride Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lurasidone Hydrochloride Generics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lurasidone Hydrochloride Generics industry.

Chapter 3: Detailed analysis of Lurasidone Hydrochloride Generics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lurasidone Hydrochloride Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lurasidone Hydrochloride Generics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lurasidone Hydrochloride Generics Industry Trends Table 2. Lurasidone Hydrochloride Generics Industry Drivers Table 3. Lurasidone Hydrochloride Generics Industry Opportunities and Challenges Table 4. Lurasidone Hydrochloride Generics Industry Restraints Table 5. Global Lurasidone Hydrochloride Generics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lurasidone Hydrochloride Generics Revenue Share by Company (2021-2026) Table 7. Global Lurasidone Hydrochloride Generics Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lurasidone Hydrochloride Generics Sales Volume Share by Company (2021-2026) Table 9. Global Lurasidone Hydrochloride Generics Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lurasidone Hydrochloride Generics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lurasidone Hydrochloride Generics Key Company Manufacturing Base & Headquarters Table 12. Global Lurasidone Hydrochloride Generics Company, Product Type & Application Table 13. Global Lurasidone Hydrochloride Generics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lurasidone Hydrochloride Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 20mg per Tablet Table 18. Significant Companies of 40mg per Tablet Table 19. Significant Companies of 60mg per Tablet Table 20. Significant Companies of 80mg per Tablet Table 21. Significant Companies of 120mg per Tablet Table 22. Global Lurasidone Hydrochloride Generics Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Lurasidone Hydrochloride Generics Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Lurasidone Hydrochloride Generics Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Lurasidone Hydrochloride Generics Sales Volume Share by Type (2021-2026) Table 26. Global Lurasidone Hydrochloride Generics Sales Volume Share by Type (2027-2032) Table 27. Global Lurasidone Hydrochloride Generics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Lurasidone Hydrochloride Generics Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Lurasidone Hydrochloride Generics Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Lurasidone Hydrochloride Generics Sales Value Share by Type (2021-2026) Table 31. Global Lurasidone Hydrochloride Generics Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Schizophrenia Table 33. Significant Companies of Bipolar Depression Table 34. Global Lurasidone Hydrochloride Generics Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Lurasidone Hydrochloride Generics Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Lurasidone Hydrochloride Generics Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Lurasidone Hydrochloride Generics Sales Volume Share by Application (2021-2026) Table 38. Global Lurasidone Hydrochloride Generics Sales Volume Share by Application (2027-2032) Table 39. Global Lurasidone Hydrochloride Generics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Lurasidone Hydrochloride Generics Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Lurasidone Hydrochloride Generics Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Lurasidone Hydrochloride Generics Sales Value Share by Application (2021-2026) Table 43. Global Lurasidone Hydrochloride Generics Sales Value Share by Application (2027-2032) Table 44. Global Lurasidone Hydrochloride Generics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Lurasidone Hydrochloride Generics Sales by Region (2021-2026) & (K Units) Table 46. Global Lurasidone Hydrochloride Generics Sales Market Share by Region (2021-2026) Table 47. Global Lurasidone Hydrochloride Generics Sales by Region (2027-2032) & (K Units) Table 48. Global Lurasidone Hydrochloride Generics Sales Market Share by Region (2027-2032) Table 49. Global Lurasidone Hydrochloride Generics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Lurasidone Hydrochloride Generics Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Lurasidone Hydrochloride Generics Sales Value Share by Region (2021-2026) Table 52. Global Lurasidone Hydrochloride Generics Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Lurasidone Hydrochloride Generics Sales Value Share by Region (2027-2032) Table 54. Global Lurasidone Hydrochloride Generics Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Lurasidone Hydrochloride Generics Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Lurasidone Hydrochloride Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Lurasidone Hydrochloride Generics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Lurasidone Hydrochloride Generics Sales by Country (2021-2026) & (K Units) Table 59. Global Lurasidone Hydrochloride Generics Sales Market Share by Country (2021-2026) Table 60. Global Lurasidone Hydrochloride Generics Sales by Country (2027-2032) & (K Units) Table 61. Global Lurasidone Hydrochloride Generics Sales Market Share by Country (2027-2032) Table 62. Global Lurasidone Hydrochloride Generics Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Lurasidone Hydrochloride Generics Sales Value Market Share by Country (2021-2026) Table 64. Global Lurasidone Hydrochloride Generics Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Lurasidone Hydrochloride Generics Sales Value Market Share by Country (2027-2032) Table 66. Chia Tai Tianqing Pharmaceutical Company Information Table 67. Chia Tai Tianqing Pharmaceutical Business Overview Table 68. Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 70. Chia Tai Tianqing Pharmaceutical Recent Development Table 71. Zhejiang Huahai Pharmaceutical Company Information Table 72. Zhejiang Huahai Pharmaceutical Business Overview Table 73. Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 75. Zhejiang Huahai Pharmaceutical Recent Development Table 76. YaoPharma Company Information Table 77. YaoPharma Business Overview Table 78. YaoPharma Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. YaoPharma Lurasidone Hydrochloride Generics Product Portfolio Table 80. YaoPharma Recent Development Table 81. Yangtze River Pharmaceutical Company Information Table 82. Yangtze River Pharmaceutical Business Overview Table 83. Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 85. Yangtze River Pharmaceutical Recent Development Table 86. SJZ No.4 Pharmaceutical Company Information Table 87. SJZ No.4 Pharmaceutical Business Overview Table 88. SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 90. SJZ No.4 Pharmaceutical Recent Development Table 91. Shandong Jewim Pharmaceutical Company Information Table 92. Shandong Jewim Pharmaceutical Business Overview Table 93. Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 95. Shandong Jewim Pharmaceutical Recent Development Table 96. Qilu Pharmaceutical Company Information Table 97. Qilu Pharmaceutical Business Overview Table 98. Qilu Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Qilu Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 100. Qilu Pharmaceutical Recent Development Table 101. Hansoh Pharma Company Information Table 102. Hansoh Pharma Business Overview Table 103. Hansoh Pharma Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hansoh Pharma Lurasidone Hydrochloride Generics Product Portfolio Table 105. Hansoh Pharma Recent Development Table 106. Hisun Pharmaceuticals Company Information Table 107. Hisun Pharmaceuticals Business Overview Table 108. Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio Table 110. Hisun Pharmaceuticals Recent Development Table 111. Cisen Pharmaceutical Company Information Table 112. Cisen Pharmaceutical Business Overview Table 113. Cisen Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Cisen Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 115. Cisen Pharmaceutical Recent Development Table 116. Changzhou Pharmaceutical Factory Company Information Table 117. Changzhou Pharmaceutical Factory Business Overview Table 118. Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Product Portfolio Table 120. Changzhou Pharmaceutical Factory Recent Development Table 121. Zydus Company Information Table 122. Zydus Business Overview Table 123. Zydus Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Zydus Lurasidone Hydrochloride Generics Product Portfolio Table 125. Zydus Recent Development Table 126. Sun Pharmaceuticals Company Information Table 127. Sun Pharmaceuticals Business Overview Table 128. Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Sun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio Table 130. Sun Pharmaceuticals Recent Development Table 131. MSN Company Information Table 132. MSN Business Overview Table 133. MSN Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. MSN Lurasidone Hydrochloride Generics Product Portfolio Table 135. MSN Recent Development Table 136. Lupin Company Information Table 137. Lupin Business Overview Table 138. Lupin Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Lupin Lurasidone Hydrochloride Generics Product Portfolio Table 140. Lupin Recent Development Table 141. Dr. Reddy's Laboratories Company Information Table 142. Dr. Reddy's Laboratories Business Overview Table 143. Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Product Portfolio Table 145. Dr. Reddy's Laboratories Recent Development Table 146. Amneal Company Information Table 147. Amneal Business Overview Table 148. Amneal Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Amneal Lurasidone Hydrochloride Generics Product Portfolio Table 150. Amneal Recent Development Table 151. Alkem Company Information Table 152. Alkem Business Overview Table 153. Alkem Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Alkem Lurasidone Hydrochloride Generics Product Portfolio Table 155. Alkem Recent Development Table 156. Alembic pharmaceuticals Company Information Table 157. Alembic pharmaceuticals Business Overview Table 158. Alembic pharmaceuticals Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Alembic pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio Table 160. Alembic pharmaceuticals Recent Development Table 161. Accord Healthcare Company Information Table 162. Accord Healthcare Business Overview Table 163. Accord Healthcare Lurasidone Hydrochloride Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Accord Healthcare Lurasidone Hydrochloride Generics Product Portfolio Table 165. Accord Healthcare Recent Development Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Lurasidone Hydrochloride Generics Distributors List Table 169. Lurasidone Hydrochloride Generics Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Lurasidone Hydrochloride Generics Product Image Figure 2. Global Lurasidone Hydrochloride Generics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lurasidone Hydrochloride Generics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lurasidone Hydrochloride Generics Sales (2021-2032) & (K Units) Figure 5. Global Lurasidone Hydrochloride Generics Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lurasidone Hydrochloride Generics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 20mg per Tablet Image Figure 10. 40mg per Tablet Image Figure 11. 60mg per Tablet Image Figure 12. 80mg per Tablet Image Figure 13. 120mg per Tablet Image Figure 14. Global Lurasidone Hydrochloride Generics Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Lurasidone Hydrochloride Generics Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Lurasidone Hydrochloride Generics Sales Volume Share by Type (2021-2032) Figure 17. Global Lurasidone Hydrochloride Generics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Lurasidone Hydrochloride Generics Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Lurasidone Hydrochloride Generics Sales Value Share by Type (2021-2032) Figure 20. Schizophrenia Image Figure 21. Bipolar Depression Image Figure 22. Global Lurasidone Hydrochloride Generics Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Lurasidone Hydrochloride Generics Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Lurasidone Hydrochloride Generics Sales Volume Share by Application (2021-2032) Figure 25. Global Lurasidone Hydrochloride Generics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Lurasidone Hydrochloride Generics Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Lurasidone Hydrochloride Generics Sales Value Share by Application (2021-2032) Figure 28. Global Lurasidone Hydrochloride Generics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Lurasidone Hydrochloride Generics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Lurasidone Hydrochloride Generics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Lurasidone Hydrochloride Generics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Lurasidone Hydrochloride Generics Sales Value (2021-2032) & (US$ Million) Figure 33. North America Lurasidone Hydrochloride Generics Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Lurasidone Hydrochloride Generics Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Lurasidone Hydrochloride Generics Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Lurasidone Hydrochloride Generics Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Lurasidone Hydrochloride Generics Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Lurasidone Hydrochloride Generics Sales Value (2021-2032) & (US$ Million) Figure 39. South America Lurasidone Hydrochloride Generics Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Lurasidone Hydrochloride Generics Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Lurasidone Hydrochloride Generics Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Lurasidone Hydrochloride Generics Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Lurasidone Hydrochloride Generics Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 20mg per Tablet
  • 40mg per Tablet
  • 60mg per Tablet
  • 80mg per Tablet
  • 120mg per Tablet
Applications
  • Schizophrenia
  • Bipolar Depression
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • Zhejiang Huahai Pharmaceutical
  • YaoPharma
  • Yangtze River Pharmaceutical
  • SJZ No.4 Pharmaceutical
  • Shandong Jewim Pharmaceutical
  • Qilu Pharmaceutical
  • Hansoh Pharma
  • Hisun Pharmaceuticals
  • Cisen Pharmaceutical
  • Changzhou Pharmaceutical Factory
  • Zydus
  • Sun Pharmaceuticals
  • MSN
  • Lupin
  • Dr. Reddy's Laboratories
  • Amneal
  • Alkem
  • Alembic pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lurasidone Hydrochloride Generics Sales Value (2021-2032)
  4. 1.2.2 Global Lurasidone Hydrochloride Generics Sales Volume (2021-2032)
  5. 1.2.3 Global Lurasidone Hydrochloride Generics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lurasidone Hydrochloride Generics Market Dynamics
  1. 2.1 Lurasidone Hydrochloride Generics Industry Trends
  2. 2.2 Lurasidone Hydrochloride Generics Industry Drivers
  3. 2.3 Lurasidone Hydrochloride Generics Industry Opportunities and Challenges
  4. 2.4 Lurasidone Hydrochloride Generics Industry Restraints
3 Lurasidone Hydrochloride Generics Market by Company
  1. 3.1 Global Lurasidone Hydrochloride Generics Company Revenue Ranking in 2025
  2. 3.2 Global Lurasidone Hydrochloride Generics Revenue by Company (2021-2026)
  3. 3.3 Global Lurasidone Hydrochloride Generics Sales Volume by Company (2021-2026)
  4. 3.4 Global Lurasidone Hydrochloride Generics Average Price by Company (2021-2026)
  5. 3.5 Global Lurasidone Hydrochloride Generics Company Ranking (2024-2026)
  6. 3.6 Global Lurasidone Hydrochloride Generics Company Manufacturing Base and Headquarters
  7. 3.7 Global Lurasidone Hydrochloride Generics Company Product Type and Application
  8. 3.8 Global Lurasidone Hydrochloride Generics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lurasidone Hydrochloride Generics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lurasidone Hydrochloride Generics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lurasidone Hydrochloride Generics Market by Type
  1. 4.1 Lurasidone Hydrochloride Generics Type Introduction
  2. 4.1.1 20mg per Tablet
  3. 4.1.2 40mg per Tablet
  4. 4.1.3 60mg per Tablet
  5. 4.1.4 80mg per Tablet
  6. 4.1.5 120mg per Tablet
  7. 4.2 Global Lurasidone Hydrochloride Generics Sales Volume by Type
  8. 4.2.1 Global Lurasidone Hydrochloride Generics Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Lurasidone Hydrochloride Generics Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Lurasidone Hydrochloride Generics Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Lurasidone Hydrochloride Generics Sales Value by Type
  12. 4.3.1 Global Lurasidone Hydrochloride Generics Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Lurasidone Hydrochloride Generics Sales Value by Type (2021-2032)
  14. 4.3.3 Global Lurasidone Hydrochloride Generics Sales Value Share by Type (2021-2032)
5 Lurasidone Hydrochloride Generics Market by Application
  1. 5.1 Lurasidone Hydrochloride Generics Application Introduction
  2. 5.1.1 Schizophrenia
  3. 5.1.2 Bipolar Depression
  4. 5.2 Global Lurasidone Hydrochloride Generics Sales Volume by Application
  5. 5.2.1 Global Lurasidone Hydrochloride Generics Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Lurasidone Hydrochloride Generics Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Lurasidone Hydrochloride Generics Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Lurasidone Hydrochloride Generics Sales Value by Application
  9. 5.3.1 Global Lurasidone Hydrochloride Generics Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Lurasidone Hydrochloride Generics Sales Value by Application (2021-2032)
  11. 5.3.3 Global Lurasidone Hydrochloride Generics Sales Value Share by Application (2021-2032)
6 Lurasidone Hydrochloride Generics Regional Sales and Value Analysis
  1. 6.1 Global Lurasidone Hydrochloride Generics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lurasidone Hydrochloride Generics Sales by Region (2021-2032)
  3. 6.2.1 Global Lurasidone Hydrochloride Generics Sales by Region: 2021-2026
  4. 6.2.2 Global Lurasidone Hydrochloride Generics Sales by Region (2027-2032)
  5. 6.3 Global Lurasidone Hydrochloride Generics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lurasidone Hydrochloride Generics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lurasidone Hydrochloride Generics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lurasidone Hydrochloride Generics Sales Value by Region (2027-2032)
  9. 6.5 Global Lurasidone Hydrochloride Generics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lurasidone Hydrochloride Generics Sales Value (2021-2032)
  12. 6.6.2 North America Lurasidone Hydrochloride Generics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lurasidone Hydrochloride Generics Sales Value (2021-2032)
  15. 6.7.2 Europe Lurasidone Hydrochloride Generics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lurasidone Hydrochloride Generics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lurasidone Hydrochloride Generics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lurasidone Hydrochloride Generics Sales Value (2021-2032)
  21. 6.9.2 South America Lurasidone Hydrochloride Generics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lurasidone Hydrochloride Generics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lurasidone Hydrochloride Generics Sales Value Share by Country, 2025 VS 2032
7 Lurasidone Hydrochloride Generics Country-level Sales and Value Analysis
  1. 7.1 Global Lurasidone Hydrochloride Generics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lurasidone Hydrochloride Generics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lurasidone Hydrochloride Generics Sales by Country (2021-2032)
  4. 7.3.1 Global Lurasidone Hydrochloride Generics Sales by Country (2021-2026)
  5. 7.3.2 Global Lurasidone Hydrochloride Generics Sales by Country (2027-2032)
  6. 7.4 Global Lurasidone Hydrochloride Generics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lurasidone Hydrochloride Generics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lurasidone Hydrochloride Generics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lurasidone Hydrochloride Generics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lurasidone Hydrochloride Generics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lurasidone Hydrochloride Generics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chia Tai Tianqing Pharmaceutical
  2. 8.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 8.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 8.1.3 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  6. 8.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 8.2 Zhejiang Huahai Pharmaceutical
  8. 8.2.1 Zhejiang Huahai Pharmaceutical Company Information
  9. 8.2.2 Zhejiang Huahai Pharmaceutical Business Overview
  10. 8.2.3 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  12. 8.2.5 Zhejiang Huahai Pharmaceutical Recent Developments
  13. 8.3 YaoPharma
  14. 8.3.1 YaoPharma Company Information
  15. 8.3.2 YaoPharma Business Overview
  16. 8.3.3 YaoPharma Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 YaoPharma Lurasidone Hydrochloride Generics Product Portfolio
  18. 8.3.5 YaoPharma Recent Developments
  19. 8.4 Yangtze River Pharmaceutical
  20. 8.4.1 Yangtze River Pharmaceutical Company Information
  21. 8.4.2 Yangtze River Pharmaceutical Business Overview
  22. 8.4.3 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  24. 8.4.5 Yangtze River Pharmaceutical Recent Developments
  25. 8.5 SJZ No.4 Pharmaceutical
  26. 8.5.1 SJZ No.4 Pharmaceutical Company Information
  27. 8.5.2 SJZ No.4 Pharmaceutical Business Overview
  28. 8.5.3 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  30. 8.5.5 SJZ No.4 Pharmaceutical Recent Developments
  31. 8.6 Shandong Jewim Pharmaceutical
  32. 8.6.1 Shandong Jewim Pharmaceutical Company Information
  33. 8.6.2 Shandong Jewim Pharmaceutical Business Overview
  34. 8.6.3 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  36. 8.6.5 Shandong Jewim Pharmaceutical Recent Developments
  37. 8.7 Qilu Pharmaceutical
  38. 8.7.1 Qilu Pharmaceutical Company Information
  39. 8.7.2 Qilu Pharmaceutical Business Overview
  40. 8.7.3 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  42. 8.7.5 Qilu Pharmaceutical Recent Developments
  43. 8.8 Hansoh Pharma
  44. 8.8.1 Hansoh Pharma Company Information
  45. 8.8.2 Hansoh Pharma Business Overview
  46. 8.8.3 Hansoh Pharma Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hansoh Pharma Lurasidone Hydrochloride Generics Product Portfolio
  48. 8.8.5 Hansoh Pharma Recent Developments
  49. 8.9 Hisun Pharmaceuticals
  50. 8.9.1 Hisun Pharmaceuticals Company Information
  51. 8.9.2 Hisun Pharmaceuticals Business Overview
  52. 8.9.3 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
  54. 8.9.5 Hisun Pharmaceuticals Recent Developments
  55. 8.10 Cisen Pharmaceutical
  56. 8.10.1 Cisen Pharmaceutical Company Information
  57. 8.10.2 Cisen Pharmaceutical Business Overview
  58. 8.10.3 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  60. 8.10.5 Cisen Pharmaceutical Recent Developments
  61. 8.11 Changzhou Pharmaceutical Factory
  62. 8.11.1 Changzhou Pharmaceutical Factory Company Information
  63. 8.11.2 Changzhou Pharmaceutical Factory Business Overview
  64. 8.11.3 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Product Portfolio
  66. 8.11.5 Changzhou Pharmaceutical Factory Recent Developments
  67. 8.12 Zydus
  68. 8.12.1 Zydus Company Information
  69. 8.12.2 Zydus Business Overview
  70. 8.12.3 Zydus Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Zydus Lurasidone Hydrochloride Generics Product Portfolio
  72. 8.12.5 Zydus Recent Developments
  73. 8.13 Sun Pharmaceuticals
  74. 8.13.1 Sun Pharmaceuticals Company Information
  75. 8.13.2 Sun Pharmaceuticals Business Overview
  76. 8.13.3 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
  78. 8.13.5 Sun Pharmaceuticals Recent Developments
  79. 8.14 MSN
  80. 8.14.1 MSN Company Information
  81. 8.14.2 MSN Business Overview
  82. 8.14.3 MSN Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 MSN Lurasidone Hydrochloride Generics Product Portfolio
  84. 8.14.5 MSN Recent Developments
  85. 8.15 Lupin
  86. 8.15.1 Lupin Company Information
  87. 8.15.2 Lupin Business Overview
  88. 8.15.3 Lupin Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Lupin Lurasidone Hydrochloride Generics Product Portfolio
  90. 8.15.5 Lupin Recent Developments
  91. 8.16 Dr. Reddy's Laboratories
  92. 8.16.1 Dr. Reddy's Laboratories Company Information
  93. 8.16.2 Dr. Reddy's Laboratories Business Overview
  94. 8.16.3 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Product Portfolio
  96. 8.16.5 Dr. Reddy's Laboratories Recent Developments
  97. 8.17 Amneal
  98. 8.17.1 Amneal Company Information
  99. 8.17.2 Amneal Business Overview
  100. 8.17.3 Amneal Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Amneal Lurasidone Hydrochloride Generics Product Portfolio
  102. 8.17.5 Amneal Recent Developments
  103. 8.18 Alkem
  104. 8.18.1 Alkem Company Information
  105. 8.18.2 Alkem Business Overview
  106. 8.18.3 Alkem Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Alkem Lurasidone Hydrochloride Generics Product Portfolio
  108. 8.18.5 Alkem Recent Developments
  109. 8.19 Alembic pharmaceuticals
  110. 8.19.1 Alembic pharmaceuticals Company Information
  111. 8.19.2 Alembic pharmaceuticals Business Overview
  112. 8.19.3 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
  114. 8.19.5 Alembic pharmaceuticals Recent Developments
  115. 8.20 Accord Healthcare
  116. 8.20.1 Accord Healthcare Company Information
  117. 8.20.2 Accord Healthcare Business Overview
  118. 8.20.3 Accord Healthcare Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Accord Healthcare Lurasidone Hydrochloride Generics Product Portfolio
  120. 8.20.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lurasidone Hydrochloride Generics Value Chain Analysis
  2. 9.1.1 Lurasidone Hydrochloride Generics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lurasidone Hydrochloride Generics Sales Mode & Process
  6. 9.2 Lurasidone Hydrochloride Generics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lurasidone Hydrochloride Generics Distributors
  9. 9.2.3 Lurasidone Hydrochloride Generics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst